《Biomedical Research-tokyo》雜志的最新年發文量為24篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章,以保持其在醫學:研究與實驗領域的學術影響力。
該刊聚焦于醫學-醫學:研究與實驗領域的前沿研究,致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 12周,或約稿 。
Biomedical Research-tokyo 雜志發文統計
文章名稱引用次數
- Tumor mutational burden analysis of 000 Japanese cancer genomes using whole exome and targeted gene panel sequencing8
- Absorption and metabolism of orally administered collagen hydrolysates evaluated by the vascularly perfused rat intestine and liver in situ5
- Antitumor activity of the PD-1/PD-L1 binding inhibitor BMS-202 in the humanized MHC-double knockout NOG mouse3
- Hypothermia induces changes in the alternative splicing pattern of cold-inducible RNA-binding protein transcripts in a non-hibernator, the mouse3
- Vascularization via activation of VEGF-VEGFR signaling is essential for peripheral nerve regeneration3
- Histone H1 quantity determines the efficiencies of apoptotic DNA fragmentation and chromatin condensation3
- Clinicopathological and prognostic significance of nuclear UGDH localization in lung adenocarcinoma3
- Kruppel-like factor 5 (Klf5) regulates expression of mouse T1R1 amino acid receptor gene (Tas1r1) in C2C12 myoblast cells2
- Gnetin C, a resveratrol dimer, reduces amyloid-beta 1-42 (A beta 42) production and ameliorates A beta 42-lowered cell viability in cultured SH-SY5Y human neuroblastoma cells2
- Effects of the calcineurin inhibitors cyclosporine and tacrolimus on bone metabolism in rats2
國家/地區發文量
- Japan85
- CHINA MAINLAND4
- USA2
- Brazil1
- Indonesia1
- Jordan1
- Thailand1
- Zambia1